Terns Pharmaceuticals (TERN) Competitors $3.00 +0.13 (+4.34%) As of 01:48 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TERN vs. AVDL, CVAC, DAWN, ABCL, PAHC, GYRE, NUVB, CRON, PHVS, and EOLSShould you be buying Terns Pharmaceuticals stock or one of its competitors? The main competitors of Terns Pharmaceuticals include Avadel Pharmaceuticals (AVDL), CureVac (CVAC), Day One Biopharmaceuticals (DAWN), AbCellera Biologics (ABCL), Phibro Animal Health (PAHC), Gyre Therapeutics (GYRE), Nuvation Bio (NUVB), Cronos Group (CRON), Pharvaris (PHVS), and Evolus (EOLS). These companies are all part of the "pharmaceutical products" industry. Terns Pharmaceuticals vs. Avadel Pharmaceuticals CureVac Day One Biopharmaceuticals AbCellera Biologics Phibro Animal Health Gyre Therapeutics Nuvation Bio Cronos Group Pharvaris Evolus Terns Pharmaceuticals (NASDAQ:TERN) and Avadel Pharmaceuticals (NASDAQ:AVDL) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, community ranking, earnings, valuation, profitability, dividends, media sentiment and institutional ownership. Is TERN or AVDL more profitable? Terns Pharmaceuticals has a net margin of 0.00% compared to Avadel Pharmaceuticals' net margin of -52.53%. Terns Pharmaceuticals' return on equity of -32.76% beat Avadel Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Terns PharmaceuticalsN/A -32.76% -31.33% Avadel Pharmaceuticals -52.53%-93.34%-44.77% Does the MarketBeat Community believe in TERN or AVDL? Avadel Pharmaceuticals received 307 more outperform votes than Terns Pharmaceuticals when rated by MarketBeat users. Likewise, 66.54% of users gave Avadel Pharmaceuticals an outperform vote while only 59.72% of users gave Terns Pharmaceuticals an outperform vote. CompanyUnderperformOutperformTerns PharmaceuticalsOutperform Votes4359.72% Underperform Votes2940.28% Avadel PharmaceuticalsOutperform Votes35066.54% Underperform Votes17633.46% Do insiders & institutionals believe in TERN or AVDL? 98.3% of Terns Pharmaceuticals shares are owned by institutional investors. Comparatively, 69.2% of Avadel Pharmaceuticals shares are owned by institutional investors. 15.1% of Terns Pharmaceuticals shares are owned by insiders. Comparatively, 4.8% of Avadel Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Which has better earnings and valuation, TERN or AVDL? Terns Pharmaceuticals has higher earnings, but lower revenue than Avadel Pharmaceuticals. Avadel Pharmaceuticals is trading at a lower price-to-earnings ratio than Terns Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTerns PharmaceuticalsN/AN/A-$90.21M-$1.13-2.55Avadel Pharmaceuticals$169.12M4.76-$160.28M-$0.52-16.01 Does the media prefer TERN or AVDL? In the previous week, Terns Pharmaceuticals had 1 more articles in the media than Avadel Pharmaceuticals. MarketBeat recorded 7 mentions for Terns Pharmaceuticals and 6 mentions for Avadel Pharmaceuticals. Terns Pharmaceuticals' average media sentiment score of 1.06 beat Avadel Pharmaceuticals' score of 1.05 indicating that Terns Pharmaceuticals is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Terns Pharmaceuticals 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Avadel Pharmaceuticals 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend TERN or AVDL? Terns Pharmaceuticals presently has a consensus price target of $18.38, indicating a potential upside of 536.92%. Avadel Pharmaceuticals has a consensus price target of $19.88, indicating a potential upside of 138.80%. Given Terns Pharmaceuticals' higher possible upside, equities research analysts plainly believe Terns Pharmaceuticals is more favorable than Avadel Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Terns Pharmaceuticals 0 Sell rating(s) 2 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.60Avadel Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has more volatility & risk, TERN or AVDL? Terns Pharmaceuticals has a beta of -0.13, suggesting that its stock price is 113% less volatile than the S&P 500. Comparatively, Avadel Pharmaceuticals has a beta of 1.52, suggesting that its stock price is 52% more volatile than the S&P 500. SummaryTerns Pharmaceuticals beats Avadel Pharmaceuticals on 10 of the 17 factors compared between the two stocks. Get Terns Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for TERN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TERN vs. The Competition Export to ExcelMetricTerns PharmaceuticalsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$249.93M$6.51B$5.35B$7.51BDividend YieldN/A3.21%5.44%4.33%P/E Ratio-2.437.0021.9818.05Price / SalesN/A260.09396.58104.31Price / CashN/A65.6738.2034.62Price / Book0.706.346.734.14Net Income-$90.21M$142.49M$3.21B$247.59M7 Day Performance19.96%6.43%3.97%3.51%1 Month Performance-17.81%-9.08%-7.02%-5.80%1 Year Performance-39.26%-2.74%15.37%2.83% Terns Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TERNTerns Pharmaceuticals4.1301 of 5 stars$3.01+4.3%$18.38+511.5%-38.6%$261.46MN/A-2.5440Analyst ForecastNews CoveragePositive NewsAVDLAvadel Pharmaceuticals1.9949 of 5 stars$7.73+0.7%$19.88+157.1%-54.1%$746.94M$169.12M-9.7870CVACCureVac3.3266 of 5 stars$3.27+2.5%$10.00+205.8%+22.5%$732.09M$543.28M5.95880Short Interest ↑DAWNDay One Biopharmaceuticals2.3881 of 5 stars$7.22+1.4%$32.29+347.2%-55.3%$731.78M$131.16M-7.0160Analyst RevisionNews CoveragePositive NewsABCLAbCellera Biologics2.4817 of 5 stars$2.44+1.7%$7.00+186.9%-36.3%$727.09M$28.83M-4.00500News CoverageGap DownPAHCPhibro Animal Health3.9156 of 5 stars$17.91+2.3%$21.00+17.3%+26.4%$725.53M$1.11B37.311,860Positive NewsGYREGyre Therapeutics0.0739 of 5 stars$7.72+2.7%N/A-42.3%$722.69M$105.76M154.4040NUVBNuvation Bio3.1822 of 5 stars$2.03+1.8%$8.75+332.1%-22.5%$673.97M$7.87M-0.9360Analyst ForecastPositive NewsCRONCronos Group1.6714 of 5 stars$1.72-1.7%$3.50+103.5%-27.5%$662.90M$117.62M-13.23450PHVSPharvaris1.4376 of 5 stars$12.62+5.2%$40.50+220.9%-30.4%$659.90MN/A-4.5130Gap UpEOLSEvolus3.587 of 5 stars$10.27+7.7%$24.67+140.2%-4.0%$653.04M$266.27M-11.29170Gap UpHigh Trading Volume Related Companies and Tools Related Companies Avadel Pharmaceuticals Competitors CureVac Competitors Day One Biopharmaceuticals Competitors AbCellera Biologics Competitors Phibro Animal Health Competitors Gyre Therapeutics Competitors Nuvation Bio Competitors Cronos Group Competitors Pharvaris Competitors Evolus Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TERN) was last updated on 4/24/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Collapse Is Already HereWhen a system is about to fail, those trained to spot it often notice before anyone else. Tim Plaehn flew high...Investors Alley | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredDo this Before Elon's Reveal on April 23rdElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terns Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Terns Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TERN Stock Free TERN Stock Alerts